SCHEMBL14224182

SCHEMBL14224182

NCC[C@H](N)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12825053 1.00
SCHEMBL381734 1.00
SCHEMBL9101436 0.89
SCHEMBL127505 0.83 SLC6A2 (0.31)
SCHEMBL1044479 0.82
SCHEMBL8235057 0.82
SCHEMBL555028 0.82
Tetrahydrofuran SCHEMBL28754477 0.82 ALDH1A1 (0.33)
SCHEMBL4537329 0.80
SCHEMBL2948865 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024049543-A1 COMPOSITIONS AND METHODS FOR TRANSGLUTAMINASE-MEDIATED ENDOCYTOSIS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2024-03-07 WO disclosed
US-20230295259-A1 Conjugated Hepcidin Mimetics PROTAGONIST THERAPEUTICS, INC. 2023-09-21 US disclosed
CN-116457000-A Conjugated hepcidin mimetics 普罗塔格尼斯特治疗股份有限公司 2023-07-18 CN disclosed
EP-4188412-A1 CONJUGATED HEPCIDIN MIMETICS Protagonist Therapeutics, Inc. (US) 2023-06-07 EP disclosed
WO-2022026631-A1 CONJUGATED HEPCIDIN MIMETICS PROTAGONIST THERAPEUTICS, INC. (US) 2022-02-03 WO disclosed
US-7361494-B1 Tetrahydropyrimidine dioxygenase gene, polypeptides encoded by said gene and method for producing the same MERCK PATENT GMBH (DE) 2008-04-22 US disclosed